COX-1-derived PGE2 and PGE2 type 1 receptors are vital for angiotensin ii-induced formation of reactive oxygen species and Ca2+ influx in the subfornical organ

American Journal of Physiology - Heart and Circulatory Physiology

Volumn 305, Issue 10, 2013, Pages

  Wang, Gang ^a   Sarkar, Pallabi ^b   Peterson, Jeffrey R ^b   Anrather, Josef ^a   Pierce, Joseph P ^a   Moore, Jamie M ^a   Feng, Ji ^a   Zhou, Ping ^a   Milner, Teresa A ^a   Pickel, Virginia M ^a   Iadecola, Costantino ^a   Davisson, Robin L ^b,c  

^a FEIL FAMILY BRAIN AND MIND RESEARCH INSTITUTE   (United States)

^b WEILL CORNELL MEDICAL COLLEGE   (United States)

^c Department of Obstetrics Gynecology   (United States)

Author keywords

Angiotensin II; Calcium channel; Hypertension; Prostaglandins; Reactive oxygen species; Slow pressor; Subfornical organ

Indexed keywords

ANGIOTENSIN 1 RECEPTOR; ANGIOTENSIN II; CALCIUM ION; CYCLOOXYGENASE 1; PHOSPHOLIPASE A2; PROSTAGLANDIN E RECEPTOR 1; PROSTAGLANDIN E2; REACTIVE OXYGEN METABOLITE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE 2; ANGIOTENSIN 1 RECEPTOR ANTAGONIST; CALCIUM CHANNEL BLOCKING AGENT; CALCIUM CHANNEL L TYPE; CYBB PROTEIN, MOUSE; CYCLOOXYGENASE 2; MEMBRANE PROTEIN; PROSTAGLANDIN SYNTHASE INHIBITOR; PTGER1 PROTEIN, MOUSE; PTGS1 PROTEIN, MOUSE; PTGS2 PROTEIN, MOUSE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE; CALCIUM CHANNEL; PROSTAGLANDIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CALCIUM TRANSPORT; CELL ULTRASTRUCTURE; CONTROLLED STUDY; EXCITATION; HYPERTENSION; MALE; MOUSE; NERVE CELL; NONHUMAN; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; SUBFORNICAL ORGAN; SYMPATHOEXCITATION; ACTION POTENTIAL; ANIMAL; BLOOD PRESSURE; C57BL MOUSE; CALCIUM SIGNALING; DEFICIENCY; DRUG EFFECTS; ENZYMOLOGY; GENETICS; KNOCKOUT MOUSE; METABOLISM; PATHOLOGY; PATHOPHYSIOLOGY; ULTRASTRUCTURE; DRUG EFFECT; SLOW-PRESSOR;

ACTION POTENTIALS; ANGIOTENSIN II; ANGIOTENSIN II TYPE 1 RECEPTOR BLOCKERS; ANIMALS; BLOOD PRESSURE; CALCIUM CHANNEL BLOCKERS; CALCIUM CHANNELS, L-TYPE; CALCIUM SIGNALING; CYCLOOXYGENASE 1; CYCLOOXYGENASE 2; CYCLOOXYGENASE INHIBITORS; DINOPROSTONE; HYPERTENSION; MEMBRANE GLYCOPROTEINS; MEMBRANE PROTEINS; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; NADPH OXIDASE; NEURONS; PHOSPHOLIPASES A2; REACTIVE OXYGEN SPECIES; RECEPTOR, ANGIOTENSIN, TYPE 1; RECEPTORS, PROSTAGLANDIN E, EP1 SUBTYPE; SUBFORNICAL ORGAN;

ANGIOTENSIN II; CALCIUM CHANNEL; HYPERTENSION; PROSTAGLANDINS; REACTIVE OXYGEN SPECIES; SLOW-PRESSOR; SUBFORNICAL ORGAN;

EID: 84887589190     PISSN: 03636135     EISSN: 15221539     Source Type: Journal    
DOI: 10.1152/ajpheart.00238.2013     Document Type: Article

References (70)

1. Ahmad AS, Yun YT, Ahmad M, Maruyama T, Dore S. Selective blockade of PGE2 EP1 receptor protects brain against experimental ischemia and excitotoxicity, and hippocampal slice cultures against oxygen- glucose deprivation. Neurotox Res 14: 343-351, 2008.
2. Amberg GC, Earley S, Glapa SA. Local regulation of arterial L-type calcium channels by reactive oxygen species. Circ Res 107: 1002-1010, 2010.
3. Anderson JW, Smith PM, Ferguson AV. Subfornical organ neurons projecting to paraventricular nucleus: whole-cell properties. Brain Res 921: 78-85, 2001.
4. Bezzi P, Carmignoto G, Pasti L, Vesce S, Rossi D, Rizzini BL, Pozzan T, Volterra A. Prostaglandins stimulate calcium-dependent glutamate release in astrocytes. Nature 391: 281-285, 1998.
5. Borgland SL, Connor M, Ryan RM, Ball HJ, Christie MJ. Prostaglandin E(2) inhibits calcium current in two sub-populations of acutely isolated mouse trigeminal sensory neurons. J Physiol 539: 433-444, 2002.
6. Cao X, Peterson JR, Wang G, Anrather J, Young CN, Guruju MR, Burmeister MA, Iadecola C, Davisson RL. Angiotensin II-dependent hypertension requires cyclooxygenase 1-derived prostaglandin E2 and EP1 receptor signaling in the subfornical organ of the brain. Hypertension 59: 869-876, 2012.
7. Capone C, Faraco G, Anrather J, Zhou P, Iadecola C. Cyclooxygenase 1-derived prostaglandin E2 and EP1 receptors are required for the cerebrovascular dysfunction induced by angiotensin II. Hypertension 55: 911-917, 2010.
8. Carlson NG, Rojas MA, Black JD, Redd JW, Hille J, Hill KE, Rose JW. Microglial inhibition of neuroprotection by antagonists of the EP1 prostaglandin E2 receptor. J Neuroinflammation 6: 5, 2009.
9. Collister JP, Hendel MD. Role of the subfornical organ in the chronic hypotensive response to losartan in normal rats. Hypertension 41: 576-582, 2003.
10. Datla SR, Griendling KK. Reactive oxygen species, NADPH oxidases, and hypertension. Hypertension 56: 325-330, 2010.
11. Davisson RL, Oliverio MI, Coffman TM, Sigmund CD. Divergent functions of angiotensin II receptor isoforms in the brain. J Clin Invest 106: 103-106, 2000.
12. Dolphin AC. Calcium channel diversity: multiple roles of calcium channel subunits. Curr Opin Neurobiol 19: 237-244, 2009.
13. Ferguson AV. Angiotensinergic regulation of autonomic and neuroendocrine outputs: critical roles for the subfornical organ and paraventricular nucleus. Neuroendocrinology 89: 370-376, 2009.
14. Ferguson AV, Bains JS. Actions of angiotensin in the subfornical organ and area postrema: implications for long term control of autonomic output. Clin Exp Pharmacol Physiol 24: 96-101, 1997.
15. Fernandez SF, Huang MH, Davidson BA, Knight PR 3rd, Izzo JL Jr. Modulation of angiotensin II responses in sympathetic neurons by cytosolic calcium. Hypertension 41: 56-63, 2003.
16. Fourcaudot E, Gambino F, Casassus G, Poulain B, Humeau Y, Luthi A. L-type voltage-dependent Ca2_ channels mediate expression of presynaptic LTP in amygdala. Nat Neurosci 12: 1093-1095, 2009.
17. Furuyashiki T, Narumiya S. Stress responses: the contribution of prostaglandin E(2) and its receptors. Nat Rev Endocrinol 7: 163-175, 2011.
18. Gebke E, Muller AR, Jurzak M, Gerstberger R. Angiotensin II-induced calcium signaling in neurons and astrocytes of rat circumventricular organs. Neuroscience 85: 509-520, 1998.
19. Gonzalez AD, Wang G, Waters EM, Gonzales KL, Speth RC, Van Kempen TA, Marques-Lopes J, Young CN, Butler SD, Davisson RL, Iadecola C, Pickel VM, Pierce JP, Milner TA. Distribution of angiotensin type 1a receptor containing cells in the brains of bacterial artificial chromosome transgenic mice. Neuroscience 226: 489-509, 2012.
20. Grosser T, Fries S, FitzGerald GA. Biological basis for the cardiovascular consequences of COX-2 inhibition: therapeutic challenges and opportunities. J Clin Invest 116: 4-15, 2006.
21. Guan Y, Zhang Y, Wu J, Qi Z, Yang G, Dou D, Gao Y, Chen L, Zhang X, Davis LS, Wei M, Fan X, Carmosino M, Hao C, Imig JD, Breyer RM, Breyer MD. Antihypertensive effects of selective prostaglandin E2 receptor subtype 1 targeting. J Clin Invest 117: 2496-2505, 2007.
22. Hendel MD, Collister JP. Contribution of the subfornical organ to angiotensin II-induced hypertension. Am J Physiol Heart Circ Physiol 288: H680-H685, 2005.
23. Hudasek K, Brown ST, Fearon IM. H2O2 regulates recombinant Ca2_ channel alpha1C subunits but does not mediate their sensitivity to acute hypoxia. Biochem Biophys Res Commun 318: 135-141, 2004.
24. Jadhav V, Jabre A, Chen MF, Lee TJ. Presynaptic prostaglandin E2 EP1-receptor facilitation of cerebral nitrergic neurogenic vasodilation. Stroke 40: 261-269, 2009.
25. Jewell ML, Breyer RM, Currie KP. Regulation of calcium channels and exocytosis in mouse adrenal chromaffin cells by prostaglandin EP3 receptors. Mol Pharmacol 79: 987-996, 2011.
26. Kaestner L, Tabellion W, Lipp P, Bernhardt I. Prostaglandin E2 activates channel-mediated calcium entry in human erythrocytes: an indication for a blood clot formation supporting process. Thromb Haemost 92: 1269-1272, 2004.
27. Kawano T, Anrather J, Zhou P, Park L, Wang G, Frys KA, Kunz A, Cho S, Orio M, Iadecola C. Prostaglandin E2 EP1 receptors: downstream effectors of COX-2 neurotoxicity. Nat Med 12: 225-229, 2006.
28. Kobayter S, Young JS, Brain KL. Prostaglandin E2 induces spontaneous rhythmic activity in mouse urinary bladder independently of efferent nerves. Br J Pharmacol 165: 401-413, 2012.
29. Leung KH, Chang RS, Lotti VJ, Roscoe WA, Smith RD, Timmermans PB, Chiu AT. AT1 receptors mediate the release of prostaglandins in porcine smooth muscle cells and rat astrocytes. Am J Hypertens 5: 648-656, 1992.
30. Li Z, Ferguson AV. Angiotensin II responsiveness of rat paraventricular and subfornical organ neurons in vitro. Neuroscience 55: 197-207, 1993.
31. Li Z, Ferguson AV. Subfornical organ efferents to paraventricular nucleus utilize angiotensin as a neurotransmitter. Am J Physiol Regul Integr Comp Physiol 265: R302-R309, 1993.
32. Linhart O, Obreja O, Kress M. The inflammatory mediators serotonin, prostaglandin E2 and bradykinin evoke calcium influx in rat sensory neurons. Neuroscience 118: 69-74, 2003.
33. Ma X, Chapleau MW, Whiteis CA, Abboud FM, Bielefeldt K. Angiotensin selectively activates a subpopulation of postganglionic sympathetic neurons in mice. Circ Res 88: 787-793, 2001.
34. Marty V, El Hachmane M, Amedee T. Dual modulation of synaptic transmission in the nucleus tractus solitarius by prostaglandin E2 synthesized downstream of IL-1beta. Eur J Neurosci 27: 3132-3150, 2008.
35. Mochizuki-Oda N, Mori K, Negishi M, Ito S. Prostaglandin E2 activates Ca2_ channels in bovine adrenal chromaffin cells. J Neurochem 56: 541-547, 1991.
36. Nagata T, Harayama N, Sasaki N, Inoue M, Tanaka K, Toyohira Y, Uezono Y, Maruyama T, Yanagihara N, Ueta Y, Shibuya I. Mechanisms of cytosolic Ca2_ suppression by prostaglandin E2 receptors in rat melanotrophs. J Neuroendocrinol 15: 33-41, 2003.
37. Navedo MF, Cheng EP, Yuan C, Votaw S, Molkentin JD, Scott JD, Santana LF. Increased coupled gating of L-type Ca2_ channels during hypertension and Timothy syndrome. Circ Res 106: 748-756, 2010.
38. Nicola C, Timoshenko AV, Dixon SJ, Lala PK, Chakraborty C. EP1 receptor-mediated migration of the first trimester human extravillous trophoblast: the role of intracellular calcium and calpain. J Clin Endocrinol Metab 90: 4736-4746, 2005.
39. Niwa K, Araki E, Morham SG, Ross ME, Iadecola C. Cyclooxygenase- 2 contributes to functional hyperemia in whisker-barrel cortex. J Neurosci 20: 763-770, 2000.
40. Niwa K, Haensel C, Ross ME, Iadecola C. Cyclooxygenase-1 participates in selected vasodilator responses of the cerebral circulation. Circ Res 88: 600-608, 2001.
41. Osborn JW, Fink GD, Sved AF, Toney GM, Raizada MK. Circulating angiotensin II and dietary salt: converging signals for neurogenic hypertension. Curr Hypertens Rep 9: 228-235, 2007.
42. Peterson JR, Burmeister MA, Tian X, Zhou Y, Guruju MR, Stupinski JA, Sharma RV, Davisson RL. Genetic silencing of Nox2 and Nox4 reveals differential roles of these NADPH oxidase homologues in the vasopressor and dipsogenic effects of brain angiotensin II. Hypertension 54: 1106-1114, 2009.
43. Pierce JP, Kievits J, Graustein B, Speth RC, Iadecola C, Milner TA. Sex differences in the subcellular distribution of angiotensin type 1 receptors and NADPH oxidase subunits in the dendrites of C1 neurons in the rat rostral ventrolateral medulla. Neuroscience 163: 329-338, 2009.
44. Poole CA, Brookes NH, Clover GM. Keratocyte networks visualised in the living cornea using vital dyes. J Cell Sci 106: 685-691, 1993.
45. Qi Z, Hao CM, Langenbach RI, Breyer RM, Redha R, Morrow JD, Breyer MD. Opposite effects of cyclooxygenase-1 and -2 activity on the pressor response to angiotensin II. J Clin Invest 110: 61-69, 2002.
46. Quinlan ME, Alberto CO, Hirasawa M. Short-term potentiation of mEPSCs requires N-, P/Q- and L-type Ca2_ channels and mitochondria in the supraoptic nucleus. J Physiol 586: 3147-3161, 2008.
47. Robinson KM, Janes MS, Pehar M, Monette JS, Ross MF, Hagen TM, Murphy MP, Beckman JS. Selective fluorescent imaging of superoxide in vivo using ethidium-based probes. Proc Natl Acad Sci USA 103: 15038-15043, 2006.
48. Saad WA, Camargo LA, Guarda IF, Santos TA. Subfornical organ mediates pressor effect of angiotensin: Influence of nitric oxide synthase inhibitors, AT(1) and AT(2) angiotensin antagonist's receptors. J Am Soc Hypertens 2: 326-331, 2008.
49. Smith PM, Ferguson AV. Circulating signals as critical regulators of autonomic state- central roles for the subfornical organ. Am J Physiol Regul Integr Comp Physiol 299: R405-R415, 2010.
50. Smyth EM, Grosser T, Wang M, Yu Y, FitzGerald GA. Prostanoids in health and disease. J Lipid Res 50, Suppl: S423-S428, 2009.
51. Takahara A. Cilnidipine: a new generation Ca channel blocker with inhibitory action on sympathetic neurotransmitter release. Cardiovasc Ther 27: 124-139, 2009.
52. Tolstykh G, de Paula PM, Mifflin S. Voltage-dependent calcium currents are enhanced in nucleus of the solitary tract neurons isolated from renal wrap hypertensive rats. Hypertension 49: 1163-1169, 2007.
53. Touyz RM. Reactive oxygen species as mediators of calcium signaling by angiotensin II: implications in vascular physiology and pathophysiology. Antioxid Redox Signal 7: 1302-1314, 2005.
54. Touyz RM, Berry C. Recent advances in angiotensin II signaling. Braz J Med Biol Res 35: 1001-1015, 2002.
55. Tsai CT, Wang DL, Chen WP, Hwang JJ, Hsieh CS, Hsu KL, Tseng CD, Lai LP, Tseng YZ, Chiang FT, Lin JL. Angiotensin II increases expression of alpha1C subunit of L-type calcium channel through a reactive oxygen species and cAMP response element-binding proteindependent pathway in HL-1 myocytes. Circ Res 100: 1476-1485, 2007.
56. Virdis A, Colucci R, Fornai M, Duranti E, Giannarelli C, Bernardini N, Segnani C, Ippolito C, Antonioli L, Blandizzi C, Taddei S, Salvetti A, Del Tacca M. Cyclooxygenase-1 is involved in endothelial dysfunction of mesenteric small arteries from angiotensin II-infused mice. Hypertension 49: 679-686, 2007.
57. Wang G, Anrather J, Glass MJ, Tarsitano MJ, Zhou P, Frys KA, Pickel VM, Iadecola C. Nox2, Ca2_, and protein kinase C play a role in angiotensin II-induced free radical production in nucleus tractus solitarius. Hypertension 48: 482-489, 2006.
58. Wang G, Anrather J, Huang J, Speth RC, Pickel VM, Iadecola C. NADPH oxidase contributes to angiotensin II signaling in the nucleus tractus solitarius. J Neurosci 24: 5516-5524, 2004.
59. Wang G, Dayanithi G, Newcomb R, Lemos JR. An R-type Ca2_ current in neurohypophysial terminals preferentially regulates oxytocin secretion. J Neurosci 19: 9235-9241, 1999.
60. Wankerl K, Weise D, Gentner R, Rumpf JJ, Classen J. L-type voltage-gated Ca2_ channels: a single molecular switch for long-term potentiation/long-term depression-like plasticity and activity-dependent metaplasticity in humans. J Neurosci 30: 6197-6204, 2010.
61. Washburn DL, Ferguson AV. Selective potentiation of N-type calcium channels by angiotensin II in rat subfornical organ neurones. J Physiol 536: 667-675, 2001.
62. Zeng Q, Han Y, Bao Y, Li W, Li X, Shen X, Wang X, Yao F, O'Rourke ST, Sun C. 20-HETE increases NADPH oxidase-derived ROS production and stimulates the L-type Ca2_ channel via a PKC-dependent mechanism in cardiomyocytes. Am J Physiol Heart Circ Physiol 299: H1109-H1117, 2010.
63. Zhang X, Dong F, Ren J, Driscoll MJ, Culver B. High dietary fat induces NADPH oxidase-associated oxidative stress and inflammation in rat cerebral cortex. Exp Neurol 191: 318-325, 2005.
64. Zhao JP, Phillips MA, Constantine-Paton M. Long-term potentiation in the juvenile superior colliculus requires simultaneous activation of NMDA receptors and L-type Ca2_ channels and reflects addition of newly functional synapses. J Neurosci 26: 12647-12655, 2006.
65. Zielonka J, Kalyanaraman B. Hydroethidine- and MitoSOX-derived red fluorescence is not a reliable indicator of intracellular superoxide formation: another inconvenient truth. Free Radic Biol Med 48: 983-1001, 2010.
66. Zimmerman MC, Davisson RL. Redox signaling in central neural regulation of cardiovascular function. Prog Biophys Mol Biol 84: 125- 149, 2004.
67. Zimmerman MC, Dunlay RP, Lazartigues E, Zhang Y, Sharma RV, Engelhardt JF, Davisson RL. Requirement for Rac1-dependent NADPH oxidase in the cardiovascular and dipsogenic actions of angiotensin II in the brain. Circ Res 95: 532-539, 2004.
68. Zimmerman MC, Lazartigues E, Lang JA, Sinnayah P, Ahmad IM, Spitz DR, Davisson RL. Superoxide mediates the actions of angiotensin II in the central nervous system. Circ Res 91: 1038-1045, 2002.
69. Zimmerman MC, Lazartigues E, Sharma RV, Davisson RL. Hypertension caused by angiotensin II infusion involves increased superoxide production in the central nervous system. Circ Res 95: 210-216, 2004.
70. Zimmerman MC, Sharma RV, Davisson RL. Superoxide mediates angiotensin II-induced influx of extracellular calcium in neural cells. Hypertension 45: 717-723, 2005.